Page 34 - Macromolecular Crystallography
P. 34

CHAPTER 2

                       High-throughput cloning, expression,

                       and purification



                       Raymond J. Owens, Joanne E. Nettleship, Nick S. Berrow,
                       Sarah Sainsbury, A. Radu Aricescu, David I. Stuart, and
                       David K. Stammers








        2.1 Introduction                             be carried out manually with appropriate equip-
                                                     ment, for example multichannel pipette dispensers.
        High-throughput sequencing of eukaryotic, viral,
                                                     The motivation to implement automation is largely
        and bacterial genomes is providing a huge database
                                                     to enable processes to be scaleable and sustainable
        of proteins with potential for structure–function
                                                     as error-free operations. In this article we review the
        analysis. In response to this opportunity, structural
                                                     technical developments that have come from struc-
        genomics projects have been initiated world-wide
                                                     tural proteomics and provide protocols for carrying
        with the aim of establishing high-throughput struc-
                                                     out cloning, expression, and purification procedures
        ture determination on a genome-wide scale. Crucial
                                                     in a relatively high-throughput (HTP) and parallel
        to this effort has been the development of protein
                                                     approach.
        production technologies for the high-throughput
        cloning, expression, and purification of proteins.
        Large-scale structural genomic projects were initi-  2.2 Cloning
        ated in the US by the National Institute of Health
        (NIH) and in Japan by the Riken Laboratory from  Two options are available for constructing the
        1998 to 2000. European projects followed, includ-  expression vectors required for protein produc-
        ing the Protein Structure Factory in Berlin (www.  tion,  namely ligation-dependent and ligation-
        proteinstrukturfabrik.de), Oxford Protein Produc-  independent cloning (LIC). The former makes use
        tion Facility (OPPF) (www.oppf.ox.ac.uk), and the  of standard restriction enzyme digestion in combi-
        EU-sponsored Structural Proteomics In Europe  nation with DNA ligation to produce the vectors.
        (SPINE: www.spineurope.org) programme. The   Whereas the latter utilizes either some form of
        scale of these projects has been smaller than the  recombination event or the production and anneal-
        US/Japan initiatives, with a focus at the outset on  ing of single-stranded overhangs, both of which
        human and viral targets. For all projects, there has  avoid the need to restriction digest the input DNA.
        been an emphasis on parallel processing, both in  Typically, in both cases the starting DNA is a PCR
        termsofmolecularcloning, expression, andpurifica-  product corresponding to the whole or part of an
        tion, driven by the need to accommodate relatively  open reading frame (ORF) produced from either
        large numbers of potential targets for structural  a genomic or cDNA template. The PCR primers
        biology at an acceptable cost. This has led to vary-  incorporate either restriction enzyme recognition
        ing degrees of automation and most of the groups  sites or the sequences required for LIC reactivity.
        involved have set up semiautomated liquid han-  By using rare cutting restriction enzyme sites, lig-
        dling systems to carry out some or all of their  ation based cloning has been used effectively for
        protocols. However, the protocols can equally well  semi-automated high-throughput cloning (Lesley

                                                                                            23
   29   30   31   32   33   34   35   36   37   38   39